YCM
Yiheng Capital Management Portfolio holdings
AUM
$276M
This Quarter Return
+16.82%
1 Year Return
+10.95%
3 Year Return
+44.87%
5 Year Return
+78.88%
10 Year Return
–
AUM
$1.29B
AUM Growth
+$1.29B
(+21%)
Cap. Flow
-$52.3M
Cap. Flow
% of AUM
-4.05%
Top 10 Holdings %
Top 10 Hldgs %
84.56%
Holding
30
New
–
Increased
5
Reduced
4
Closed
4
Top Buys
| 1 |
Bilibili
BILI
|
$28.4M |
| 2 |
Viridian Therapeutics
VRDN
|
$17.2M |
| 3 |
JD.com
JD
|
$6.45M |
| 4 |
Beam Therapeutics
BEAM
|
$3.91M |
| 5 |
Generation Bio
GBIO
|
$741K |
Top Sells
| 1 |
Akero Therapeutics
AKRO
|
$34.5M |
| 2 |
JOYY
JOYY Inc. American Depositary Shares
JOYY
|
$28.5M |
| 3 |
MYND
Mynd.ai
MYND
|
$14.8M |
| 4 |
Huazhu Hotels Group
HTHT
|
$12.2M |
| 5 |
ZH
Zhihu
ZH
|
$8.22M |
Sector Composition
| 1 | Communication Services | 21.41% |
| 2 | Healthcare | 19.3% |
| 3 | Consumer Discretionary | 17.77% |
| 4 | Consumer Staples | 11.77% |
| 5 | Technology | 11.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Bilibili
BILI
$9.6B
| $271M | 12.01% | 11,451,017 +1,200,846 | +12% | +$28.4M |
|
2
New Oriental
EDU
$7.85B
| $137M | 6.08% | 3,942,372 | – | – |
|
|
3
Huazhu Hotels Group
HTHT
$11.3B
| $118M | 5.23% | 2,783,620 -287,290 | -9% | -$12.2M |
|
|
4
JD.com
JD
$44.1B
| $104M | 4.62% | 1,860,440 +114,900 | +7% | +$6.45M |
|
|
NOAH
5
Noah Holdings
NOAH
$824M
| $104M | 4.61% | 6,719,722 | – | – |
|
|
6
Akero Therapeutics
AKRO
$3.74B
| $80.5M | 3.56% | 1,468,905 -630,241 | -30% | -$34.5M |
|
|
ISEE
7
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $77.4M | 3.42% | 3,613,254 | – | – |
|
8
TransDigm Group
TDG
$78.8B
| $67.8M | 3% | 107,612 | – | – |
|
|
HOLI
9
DELISTED
Hollsys Automation Technologies INTERNATIONAL, LTD. COMMON (British Virgin Island)
HOLI
| $65.1M | 2.88% | 3,963,836 | – | – |
|
10
Sabre
SABR
$706M
| $64.4M | 2.85% | 10,421,742 | – | – |
|
|
PENG
11
Penguin Solutions, Inc. Ordinary Shares
PENG
$1.26B
| $44M | 1.95% | 2,953,992 | – | – |
|
|
HIMX
12
Himax Technologies
HIMX
$1.42B
| $31.8M | 1.41% | 5,127,716 | – | – |
|
13
Denali Therapeutics
DNLI
$2.23B
| $28.2M | 1.25% | 1,014,684 | – | – |
|
|
14
Viridian Therapeutics
VRDN
$1.5B
| $28.1M | 1.25% | 963,256 +590,205 | +158% | +$17.2M |
|
|
15
Beam Therapeutics
BEAM
$1.66B
| $18.1M | 0.8% | 463,800 +100,000 | +27% | +$3.91M |
|
16
TAL Education Group
TAL
$6.46B
| $14.5M | 0.64% | 2,052,400 | – | – |
|
|
IVA
17
Inventiva
IVA
$861M
| $11.8M | 0.52% | 2,644,926 | – | – |
|
|
NIU
18
Niu Technologies
NIU
$341M
| $6.08M | 0.27% | 1,162,675 | – | – |
|
|
ZH
19
Zhihu
ZH
$421M
| $4.7M | 0.21% | 3,618,353 -6,326,239 | -64% | -$8.22M |
|
|
20
Generation Bio
GBIO
$40.4M
| $4.66M | 0.21% | 1,186,295 +188,438 | +19% | +$741K |
|
21
ACM Research
ACMR
$1.81B
| $2.33M | 0.1% | 302,300 | – | – |
|
|
SQNS
22
Sequans Communications
SQNS
$129M
| $1.94M | 0.09% | 584,260 | – | – |
|
23
CommScope
COMM
$3.55B
| $1.47M | 0.07% | 200,004 | – | – |
|
|
MYND
24
Mynd.ai
MYND
$26.8M
| $772K | 0.03% | 68,050 -1,306,501 | -95% | -$14.8M |
|
|
RERE
25
ATRenew
RERE
$1.05B
| $472K | 0.02% | 163,476 | – | – |
|